Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Worldwide Offices
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Report on Europe precision medicine Market Size & Share Worth USD 27469 Million, to Record a 10.7% CAGR by 2028 | Europe precision medicine Industry Trends, Segmentation, Analysis & Forecast by Zion Market Research

      This image opens in the lightbox

      News provided by

      Zion Market Research

      16 May, 2022, 16:30 GMT

      Share this article

      Share this article


      NEW YORK, May 16, 2022 /PRNewswire/ -- As per Zion Market Research study, The global Europe precision medicine market was worth around USD 14,926.5 million in 2021 and is estimated to grow to about USD 27469 million by 2028, with a compound annual growth rate (CAGR) of approximately 10.7 percent over the forecast period. The report analyzes the Europe precision medicine market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Europe precision medicine market.

      Key Industry Insights & Finding of the Europe precision medicine Market Reports:

      • As per the analysis shared by our research analyst, the Europe precision medicine Market is expected to grow annually at a CAGR of around 10.7 % (2022-2028).
      • Through the primary research, it was established that the Europe precision medicine Market was valued approximately USD 14,926.5 Million in 2021 and is projected to reach to roughly USD 27469 Million by 2028.
      • Europe is anticipated to see high demand for precision medicine owing to rising investments in the healthcare sector to advance healthcare facilities and provide better treatment opportunities.
      • The United Kingdom holds a major market share in the Europe precision medicine industry landscape and is expected to maintain this stance over the forecast period as well.
      • France, Germany, Spain, and Italy are also expected to be highly lucrative markets owing to increasing investments in the advancement of healthcare infrastructure.

      Zion Market Research published the latest report titled as  "Europe precision medicine Market By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technologies), By Application (Oncology, CNS, Immunology, Respiratory, Other Applications), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028" into their research database.

      Europe precision medicine Market: Overview

      Precision medicine has gained popularity across the world and this trend is anticipated to be prominent in the European region as well. –Increasing prevalence of chronic diseases, rising geriatric population, high research and development activity, and presence of key precision medicine manufacturers are some of the major factors that drive the Europe precision medicine market potential.

      Increasing investments in healthcare infrastructure will further bolster the Europe precision medicine market potential in the long run. Rising instances of cancer are also projected to provide an impetus to the Europe precision medicine market growth through 2028.

      However, the high costs associated with maintenance and installation of precision medical devices are expected to have a hindering effect on the global Europe precision medicine market growth over the forecast period.

      Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/europe-precision-medicine-market

      Our Free Sample Report Includes:

      • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
      • COVID-19 Pandemic Outbreak Impact Analysis Included
      • 175 + Pages Research Report (Inclusion of Updated Research)
      • Provide Chapter-wise guidance on Request
      • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
      • Includes Updated List of tables & figures
      • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
      • Zion Market Research methodology

      Industry Dynamics:

      Europe precision medicine Market: Growth Dynamics

      Drivers:  Increasing Research and Development Activity.

      There have been substantial advancements in the global healthcare industry and this trend is anticipated to boost the Europe precision medicine market potential over the forecast period. As the prevalence of chronic diseases is increasing and the demand for better treatment and diagnosis as well, the Europe precision medicine market is expected to see high demand. Increasing investments in research and development by healthcare companies and governments alike are expected to be prominent trends driving the Europe precision medicine market potential through 2028. 

      Restraints: High Installation and Maintenance Costs to Hamper growth.

      Precision medicine requires special equipment which is high in cost and is also costly to install and maintain and this factor alone is anticipated to have a major hindering effect on the Europe precision medicine market growth over the forecast period. Europe precision medicine companies are focusing on finding more affordable solutions to boost the adoption of precision medicine in Europe.

      Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/europe-precision-medicine-market

      Global Europe precision medicine Market: Segmentation

      • The global Europe precision medicine market is segregated based on technology, application, and region.

      By Application, the Europe precision medicine market is segmented into Oncology, CNS, Immunology, Respiratory, and Other Applications. The oncology segment is projected to be the most lucrative in the Europe precision medicine market landscape over the forecast period. Increasing demand for novel treatments for cancer and rising instances of cancer will majorly shape the growth in this segment through 2028.  

      Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/europe-precision-medicine-market

      List of Key Players of  Europe precision medicine Market:

      • 23andMe
      • Allscripts Healthcare LLC
      • Astarte Medical
      • AstraZeneca PLC
      • Biogen
      • Bristol-Myers Squibb
      • F Hoffmann-La Roche AG
      • Kailos Genetics Inc.
      • Laboratory Corporation of America Holdings
      • Medtronic PLC
      • Myriad Genetics Inc.
      • Novartis AG
      • Pfizer Inc.
      • Qiagen NV
      • Quest Diagnostics
      • Thermo Fisher Scientific Inc.

      Key questions answered in this report:

      • What are the growth rate forecast and market size for Europe precision medicine Market?
      • What are the key driving factors propelling the Europe precision medicine Market forward?
      • What are the most important companies in the Europe precision medicine Market Industry?
      • What segments does the Europe precision medicine Market cover?
      • How can I receive a free copy of the Europe precision medicine Market sample report and company profiles?

      Report Scope:

      Report Attribute

      Details

      Market size value in 2021

      USD 14,926.5 Million

      Revenue forecast in 2028

      USD 27469 Million

      Growth Rate

      CAGR of almost 10.7 % 2022-2028

      Base Year

      2020

      Historic Years

      2016 - 2021

      Forecast Years

      2022 - 2028

      Segments Covered

      By Product Type, By Application, and By End Use

      Forecast Units

      Value (USD Million), and Volume (Units)

      Quantitative Units

      Revenue in USD million/billion and CAGR from 2022 to 2028

      Regions Covered

      North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

      Countries Covered

      U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

      Companies Covered

      23andMe, Allscripts Healthcare LLC, Astarte Medical, AstraZeneca PLC, Biogen, Bristol-Myers Squibb, F Hoffmann-La Roche AG, Kailos Genetics Inc., Laboratory Corporation of America Holdings, Medtronic PLC, Myriad Genetics Inc., Novartis AG, Pfizer Inc., Qiagen NV, Quest Diagnostics, Thermo Fisher Scientific Inc.

      Report Coverage

      Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

      Customization Scope

      Avail customized purchase options to meet your exact research needs.  

      https://www.zionmarketresearch.com/custom/2578

       Free Brochure: https://www.zionmarketresearch.com/requestbrochure/europe-precision-medicine-market

      Regional Dominance:

      • Increasing demand for better treatment and diagnosis.

      Europe is anticipated to see high demand for precision medicine owing to rising investments in the healthcare sector to advance healthcare facilities and provide better treatment opportunities. Increasing support from government initiatives to boost the adoption of precision medicine will also majorly influence Europe's precision medicine market potential through 2028. The United Kingdom holds a major market share in the Europe precision medicine industry landscape and is expected to maintain this stance over the forecast period as well. Increasing research activity and the rising use of genome analysis are other factors that will drive the market potential in the United Kingdom through 2028. France, Germany, Spain, and Italy are also expected to be highly lucrative markets owing to increasing investments in the advancement of healthcare infrastructure.  Increasing demand for better treatment and diagnosis will be a major trend prevalent in all countries in Europe.

      Global Europe precision medicine Market is segmented as follows:

      Europe precision medicine Market: By Technology Outlook (2022-2028)

      • Big Data Analytics
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Companion Diagnostics
      • Other Technologies

      Europe precision medicine Market: By Application Outlook (2022-2028)

      • Oncology
      • CNS
      • Immunology
      • Respiratory
      • Other Applications

      Europe precision medicine Market: By Region Outlook (2022-2028)

      North America

      • The U.S.
      • Canada

      Europe

      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Rest of Europe

      Asia Pacific

      • China
      • Japan
      • India
      • South Korea
      • Southeast Asia
      • Rest of Asia Pacific

      Latin America

      • Brazil
      • Mexico
      • Rest of Latin America

      Middle East & Africa

      • GCC
      • South Africa
      • Rest of Middle East & Africa

      Press Release For Europe precision medicine Market: https://www.zionmarketresearch.com/news/global-europe-precision-medicine-market

      Browse Other Related Research Reports from Zion Market Research

      • Pharmaceutical Sterility Testing Market - Global Industry Analysis: The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028.
      • Respiratory Disorders Treatment Market - Global Industry Analysis: The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.
      • Medical Enzyme Technology Market - Global Industry Analysis: The global Medical Enzyme Technology market accrued earnings worth approximately 4.5(USD Billion) in 2020 and is predicted to gain revenue of about 6.7(USD Billion) by 2028, is set to record a CAGR of nearly 6.2% over the period from 2021 to 2028.

      Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry

      Follow Us on: LinkedIn | Twitter | Facebook

      About Us

      Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

      Contact Us:
      Zion Market Research
      244 Fifth Avenue, Suite N202
      New York, 10001, United States
      Tel: +49-322 210 92714
      USA/Canada Toll Free No.1-855-465-4651
      Email: sales@zionmarketresearch.com 
      Website: https://www.zionmarketresearch.com/ 
      Blog - https://zmrblog.com/

      Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.